Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB
Go back to Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB| (NASDAQ: AKTS) | Delayed: 24.79 +0.70 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.09 | 52 Week High | $5.77 | |||
| Open | $24.35 | 52 Week Low | $1.51 | |||
| Day High | $25.34 | P/E | N/A | |||
| Day Low | $24.14 | EPS | $0.00 | |||
| Volume | 361,646 | |||||
| Avalon Technology Group, Inc. (NASDAQ: AVLN) | Delayed: 32.97 +1.52 (4.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.45 | 52 Week High | $0.00 | |||
| Open | $31.71 | 52 Week Low | $0.00 | |||
| Day High | $33.19 | P/E | N/A | |||
| Day Low | $30.27 | EPS | $0.00 | |||
| Volume | 503,897 | |||||
| (NYSE: UCB) | Delayed: 33.38 +0.53 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.85 | 52 Week High | $ | |||
| Open | $32.96 | 52 Week Low | $ | |||
| Day High | $33.40 | P/E | N/A | |||
| Day Low | $32.85 | EPS | $ | |||
| Volume | 1,070,341 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 141.43 -1.7 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.13 | 52 Week High | $46.25 | |||
| Open | $139.93 | 52 Week Low | $32.74 | |||
| Day High | $141.79 | P/E | N/A | |||
| Day Low | $139.54 | EPS | $0.00 | |||
| Volume | 39,487 | |||||
